# Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis

> **NCT07523165** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Guangzhou Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Lifei Qingchang Granules
- **OTHER:** Placebo
- **PROCEDURE:** Postural Drainage

## Key facts

- **NCT ID:** NCT07523165
- **Lead sponsor:** The First Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-03
- **Final completion:** 2028-04
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07523165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07523165, "Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07523165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*